Cutaneous events during anti-tumour necrosis factor (anti-TNF) treatment at a London Inflammatory Bowel Disease (IBD) centre

被引：0
|
作者：
Lim, C. [1 ]
Shepherd, T. [2 ]
Cronin, E. [2 ]
Greveson, K. [2 ]
Hamilton, M. [2 ]
Murray, C. [2 ]
机构：
[1] UCL, Gastroenterol, London, England
[2] Royal Free London NHS Fdn Trust, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P458
引用
收藏
页码：S308 / S309
页数：2
相关论文
共 50 条
  • [31] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    [J]. Arthritis Research & Therapy, 4 (1)
  • [32] Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease
    Buisson, A.
    Cuny, J. -F.
    Barbaud, A.
    Schmutz, J. -L.
    Bigard, M. -A.
    Gueant, J. -L.
    Peyrin-Biroulet, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (10) : 1175 - 1180
  • [33] Therapeutic drug monitoring of anti-tumour necrosis factor-a agents in inflammatory bowel disease
    Mitrev, Nikola
    Leong, Rupert W.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 303 - 317
  • [34] ANTI-TUMOUR NECROSIS FACTOR-ALFA DRUG MONITORING IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE
    Muhammed, R.
    Wong, T.
    Haller, W.
    Bremner, R.
    Protheroe, S.
    [J]. GUT, 2015, 64 : A432 - A433
  • [35] The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease
    Shale, Matthew J.
    [J]. BRITISH MEDICAL BULLETIN, 2009, 92 (01) : 61 - 77
  • [36] Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients
    Peer, Faseeha C.
    Miller, Andrew
    Pavli, Paul
    Subramaniam, Kavitha
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 (12) : 1445 - 1448
  • [37] Loss of response to anti-TNF in inflammatory bowel disease in a Portuguese centre
    Sousa, M.
    Silva, A. P.
    Rodrigues, A.
    Rodrigues, J.
    Silva, J.
    Gomes, C.
    Proenca, L.
    Carvalho, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S313 - S314
  • [38] Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel disease
    Tournier, Quentin
    Paul, Stephane
    Williet, Nicolas
    Berger, Anne-Emmanuelle
    Veyrard, Pauline
    Boschetti, Gilles
    Le Roy, Bertrand
    Killian, Martin
    Phelip, Jean Marc
    Flourie, Bernard
    Nancey, Stephane
    Roblin, Xavier
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (11) : 1190 - 1200
  • [39] Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
    Vavricka, Stephan R.
    Gubler, Martin
    Gantenbein, Claudine
    Spoerri, Muriel
    Froehlich, Florian
    Seibold, Frank
    Protic, Marijana
    Michetti, Pierre
    Straumann, Alex
    Fournier, Nicolas
    Juillerat, Pascal
    Biedermann, Luc
    Zeitz, Jonas
    Misselwitz, Benjamin
    Scharl, Michael
    Heinrich, Henriette
    Manser, Christine N.
    Safroneeva, Ekaterina
    Ali, Raja Affendi Raja
    Rogler, Gerhard
    Schoepfer, Alain M.
    Greuter, Thomas
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (07) : 1174 - 1181
  • [40] Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
    Vavricka, Stephan
    Biedermann, Luc
    Scharl, Michael
    Rogler, Gerhard
    Safroneeva, Ekaterina
    Schoepfer, Alain M.
    Greuter, Thomas
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 6S - 6S
12345